[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Nephrology and Urology Devices Market Outlook to 2025 - Renal Dialysis Equipment

April 2020 | 153 pages | ID: UC6156F21721EN
GlobalData

US$ 5,995.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
United States Nephrology and Urology Devices Market Outlook to 2025 - Renal Dialysis Equipment

SUMMARY

GlobalData’s “United States Nephrology and Urology Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Renal Dialysis Equipment.
The United States Nephrology and Urology Devices Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Nephrology and Urology Devices Market.
  • Global corporate-level profiles of key companies operating within the United States Nephrology and Urology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
SCOPE

United States Nephrology and Urology Devices is segmented as follows -
  • Renal Dialysis Equipment
REASONS TO BUY

The United States Nephrology and Urology Devices Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What Is This Report About?
2.2 Nephrology and Urology Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 NEPHROLOGY AND UROLOGY DEVICES MARKET, UNITED STATES

3.1 Nephrology and Urology Devices Market, United States, Revenue ($m), 2015-2025
3.2 Nephrology and Urology Devices Market, United States, Revenue ($m), 2015-2025
3.3 Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025
3.4 Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025
3.5 Nephrology and Urology Devices Market, United States, Company Share by Revenue ($m), 2019

4 RENAL DIALYSIS EQUIPMENT MARKET, UNITED STATES

4.1 Renal Dialysis Equipment Market, United States, Revenue Mix ($m), 2019
4.2 Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2019
4.3 Renal Dialysis Equipment Market, United States, Revenue ($m), 2015-2025
  4.3.1 Dialysis Accessories Market, United States, Revenue ($m), by Segment, 2015-2025
  4.3.2 Dialysis Machines Market, United States, Revenue ($m), by Segment, 2015-2025
  4.3.3 Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), by Segment, 2015-2025
4.4 Renal Dialysis Equipment Market, United States, Volume (Units), 2015-2025
  4.4.1 Dialysis Accessories Market, United States, Volume (Units) by Segment, 2015-2025
  4.4.2 Dialysis Machines Market, United States, Volume (Units) by Segment, 2015-2025
  4.4.3 Vascular Access Devices for Hemodialysis Market, United States, Volume (Units) by Segment, 2015-2025
4.5 Renal Dialysis Equipment Market, United States, Average Price ($), 2015-2025
4.6 Renal Dialysis Equipment Market, United States, Distribution Share by Revenue ($m), 2019
4.7 Renal Dialysis Equipment Market, United States, Company Share by Revenue ($m), 2019

5 OVERVIEW OF KEY COMPANIES IN UNITED STATES, NEPHROLOGY AND UROLOGY DEVICES MARKET

5.1 Fresenius Medical Care AG & Co KGaA
  5.1.1 Company Overview
5.2 Baxter International Inc
  5.2.1 Company Overview
5.3 Nipro Corp
  5.3.1 Company Overview
5.4 B. Braun Melsungen AG
  5.4.1 Company Overview
5.5 CR Bard Inc
  5.5.1 Company Overview
5.6 Asahi Kasei Corp
  5.6.1 Company Overview
5.7 Toray Medical Co Ltd
  5.7.1 Company Overview
5.8 Medtronic plc
  5.8.1 Company Overview

6 NEPHROLOGY AND UROLOGY DEVICES MARKET PIPELINE PRODUCTS

7 FINANCIAL DEALS LANDSCAPE

7.1 Acquisition
  7.1.1 Laborie Medical Acquires Clinical Innovations
  7.1.2 ICU Medical Acquires Pursuit Vascular
  7.1.3 Merit Medical Acquires Brightwater Medical
  7.1.4 Varian Medical Systems Acquires Endocare
7.2 Asset Transactions
  7.2.1 Nipro Medical Acquires Dialysate Manufacturing Business from Dimesol USA
  7.2.2 ConvaTec Group to Acquire Assets of Southlake Medical Supplies
  7.2.3 IRRAS Acquires Assets and Intellectual Property of DermaPort from AMI-USC
7.3 Debt Offerings
  7.3.1 Baxter International Raises USD500 Million in Private Placement of 3.95% Senior Notes Due 2030
  7.3.2 Baxter International Raises USD750 Million in Private Placement of 3.75% Senior Notes Due 2025
  7.3.3 Sientra Raises USD60 Million in Private Placement of Convertible Notes
  7.3.4 Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031
  7.3.5 Stryker Raises USD881.3 Million in Public Offering of 0.75% Notes Due 2029
  7.3.6 Stryker Raises USD936.4 Million in Public Offering of 0.25% Notes Due 2024
  7.3.7 Boston Scientific Raises USD999.2 Million in Public Offering of 0.625% Notes Due 2027
  7.3.8 Mesa Laboratories Raises USD172.5 Million in Public Offering of 1.375% Convertible Senior Notes due 2025
  7.3.9 Mesa Labs Raises USD172.5 Million in Public Offering of 1.375% Notes Due 2025
  7.3.10 Dentsply Sirona to Raise USD116.98 Million in Private Placement of Series W 0.99% Senior Notes Due 2031
  7.3.11 Rennova Health (CollabRx) Raises USD0.12 Million in Debt Funding
7.4 Equity Offerings
  7.4.1 Immunic Therapeutics Plans to Raise up to USD15.84 Million in Public Offering of Shares
  7.4.2 Aytu BioScience Prices Placement of Shares and Warrants for USD20 Million
  7.4.3 Aethlon Medical Plans to Raise up to USD25 Million in Public Offering of Securities
  7.4.4 Aethlon Medical to Raise up to USD7.5 Million in Public Offering of Shares
  7.4.5 Aytu BioScience Prices Placement of Shares and Warrants for USD20 Million
  7.4.6 Aytu BioScience Prices Placement of Shares for USD9 Million
  7.4.7 Hancock Jaffe Labs Raises USD0.7 Million in Private Placement of Securities
  7.4.8 Rockwell Medical Prices Public Offering of Shares for USD7.5 Million
  7.4.9 Nephros Prices Public Offering of Shares for USD7.5 Million
  7.4.10 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million
  7.4.11 Aethlon Medical Raises USD3.8 Million in Private Placement of Shares and Warrants
  7.4.12 Aethlon Medical Raises USD5 Million in Public Offering of Shares
  7.4.13 Viveve Medical Raises USD10 Million in Public Offering of Units
  7.4.14 Aytu BioScience to Raise USD10 Million in Private Placement of Preferred Shares and Warrants
  7.4.15 Viveve Medical Files Registration Statement for Public Offering of Units for up to USD8 Million
  7.4.16 Mesa Laboratories Raises USD90.6 Million in Public Offering of Common Stock
  7.4.17 Mesa Labs Raises USD90.6 Million in Public Offering of Shares
  7.4.18 NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock
  7.4.19 Rockwell Medical Raises USD17.5 Million in Public Offering of Common Stock
  7.4.20 Hancock Jaffe Laboratories Prices Public Offering of Shares for USD3.9 Million
  7.4.21 Nephros to Raise USD2 Million in Private Placement of Shares
  7.4.22 Aethlon Medical to Raise Up to USD1.25 Million Public Offering of Common Stock
  7.4.23 Sientra Raises USD115 Million in Public Offering of Shares
7.5 Merger
  7.5.1 Salter Labs and SunMed Holdings Merge
7.6 Partnerships
  7.6.1 Olympus Enters into Distribution Agreement with Rocamed
  7.6.2 CorTechs Labs and Imaging Biometrics Enter into Distribution Agreement
7.7 Private Equity
  7.7.1 Osprey Medical to Raise up to USD9.4 Million in Entitlement Offer of CDI
  7.7.2 Rockwell Medical to Raise USD15 Million in Private Financing
7.8 Venture Financing
  7.8.1 Flow Forward Medical to Raise Funds through Venture Financing
  7.8.2 US Kidney Research Raises USD0.5 Million in Venture Financing
  7.8.3 Outset Medical Raises USD125 Million in Series E Financing
  7.8.4 Solace Therapeutics Raises USD4 Million in Venture Financing
  7.8.5 Kyra Medical Raises USD0.1 Million in Venture Financing
  7.8.6 Kyra Medical Raises USD0.16 Million in Venture Financing
  7.8.7 SonoMotion Raises USD10 Million in Series B Financing
  7.8.8 Pelvital USA Raises USD1 Million in Venture Financing
  7.8.9 Kalera Medical Raises Funds through Venture Financing
  7.8.10 Healionics Raises USD4.5 Million in Financing Round
  7.8.11 MediBeacon Raises USD34.3 Million in Venture Financing
  7.8.12 Renalert Raises Funds through Venture Financing
  7.8.13 VenoStent Raises USD0.3 Million in Venture Financing
  7.8.14 Corinth MedTech Raises USD12 Million in Series D Financing
  7.8.15 Diality Raises USD10 Million in Series A Financing
  7.8.16 Kyra Medical Raises USD0.2 Million in Venture Financing
  7.8.17 Vesiflo Raises USD0.1 Million in Venture Financing
  7.8.18 ClearFlow Raises USD7.6 Million in Venture Financing
  7.8.19 Kalera Medical Raises USD0.5 Million in Venture Financing
  7.8.20 Sonomotion Raises USD3.3 Million in Venture Financing
  7.8.21 HistoSonics Raises USD54 Million in Series C Financing

8 APPENDIX

8.1 Research Methodology
  8.1.1 Coverage
  8.1.2 Secondary Research
  8.1.3 Primary Research
  8.1.4 Market Modeling and Forecasting
  8.1.5 Company Share Analysis
  8.1.6 Distribution Share Analysis
  8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer

LIST OF TABLES

Table 1: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Table 2: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 3: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 4: Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025
Table 5: Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2020
Table 6: Nephrology and Urology Devices Market, United States, Volume (Units), 2021-2025
Table 7: Nephrology and Urology Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 8: Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2019
Table 9: Renal Dialysis Equipment Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Renal Dialysis Equipment Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Dialysis Accessories Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 12: Dialysis Accessories Market, United States, Revenue ($m) USD Constant, 2021-2025
Table 13: Dialysis Machines Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 14: Dialysis Machines Market, United States, Revenue ($m) USD Constant, 2021-2025
Table 15: Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 16: Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m) USD Constant, 2021-2025
Table 17: Renal Dialysis Equipment Market, United States, Volume (Units), 2015-2020
Table 18: Renal Dialysis Equipment Market, United States, Volume (Units), 2021-2025
Table 19: Dialysis Accessories Market, United States, Volume (Units), 2015-2020
Table 20: Dialysis Accessories Market, United States, Volume (Units), 2021-2025
Table 21: Dialysis Machines Market, United States, Volume (Units), 2015-2020
Table 22: Dialysis Machines Market, United States, Volume (Units), 2021-2025
Table 23: Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), 2015-2020
Table 24: Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), 2021-2025
Table 25: Renal Dialysis Equipment Market, United States, Average Price ($), 2015-2020
Table 26: Renal Dialysis Equipment Market, United States, Average Price ($), 2021-2025
Table 27: Renal Dialysis Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019
Table 28: Renal Dialysis Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 29: Nephrology and Urology Devices Market Pipeline Products
Table 30: Laborie Medical Acquires Clinical Innovations
Table 31: ICU Medical Acquires Pursuit Vascular
Table 32: Merit Medical Acquires Brightwater Medical
Table 33: Varian Medical Systems Acquires Endocare
Table 34: Nipro Medical Acquires Dialysate Manufacturing Business from Dimesol USA
Table 35: ConvaTec Group to Acquire Assets of Southlake Medical Supplies
Table 36: IRRAS Acquires Assets and Intellectual Property of DermaPort from AMI-USC
Table 37: Baxter International Raises USD500 Million in Private Placement of 3.95% Senior Notes Due 2030
Table 38: Baxter International Raises USD750 Million in Private Placement of 3.75% Senior Notes Due 2025
Table 39: Sientra Raises USD60 Million in Private Placement of Convertible Notes
Table 40: Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031
Table 41: Stryker Raises USD881.3 Million in Public Offering of 0.75% Notes Due 2029
Table 42: Stryker Raises USD936.4 Million in Public Offering of 0.25% Notes Due 2024
Table 43: Boston Scientific Raises USD999.2 Million in Public Offering of 0.625% Notes Due 2027
Table 44: Mesa Laboratories Raises USD172.5 Million in Public Offering of 1.375% Convertible Senior Notes due 2025
Table 45: Mesa Labs Raises USD172.5 Million in Public Offering of 1.375% Notes Due 2025
Table 46: Dentsply Sirona to Raise USD116.98 Million in Private Placement of Series W 0.99% Senior Notes Due 2031
Table 47: Rennova Health (CollabRx) Raises USD0.12 Million in Debt Funding
Table 48: Immunic Therapeutics Plans to Raise up to USD15.84 Million in Public Offering of Shares
Table 49: Aytu BioScience Prices Placement of Shares and Warrants for USD20 Million
Table 50: Aethlon Medical Plans to Raise up to USD25 Million in Public Offering of Securities
Table 51: Aethlon Medical to Raise up to USD7.5 Million in Public Offering of Shares
Table 52: Aytu BioScience Prices Placement of Shares and Warrants for USD20 Million
Table 53: Aytu BioScience Prices Placement of Shares for USD9 Million
Table 54: Hancock Jaffe Labs Raises USD0.7 Million in Private Placement of Securities
Table 55: Rockwell Medical Prices Public Offering of Shares for USD7.5 Million
Table 56: Nephros Prices Public Offering of Shares for USD7.5 Million
Table 57: NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million
Table 58: Aethlon Medical Raises USD3.8 Million in Private Placement of Shares and Warrants
Table 59: Aethlon Medical Raises USD5 Million in Public Offering of Shares
Table 60: Viveve Medical Raises USD10 Million in Public Offering of Units
Table 61: Aytu BioScience to Raise USD10 Million in Private Placement of Preferred Shares and Warrants
Table 62: Viveve Medical Files Registration Statement for Public Offering of Units for up to USD8 Million
Table 63: Mesa Laboratories Raises USD90.6 Million in Public Offering of Common Stock
Table 64: Mesa Labs Raises USD90.6 Million in Public Offering of Shares
Table 65: NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock
Table 66: Rockwell Medical Raises USD17.5 Million in Public Offering of Common Stock
Table 67: Hancock Jaffe Laboratories Prices Public Offering of Shares for USD3.9 Million
Table 68: Nephros to Raise USD2 Million in Private Placement of Shares
Table 69: Aethlon Medical to Raise Up to USD1.25 Million Public Offering of Common Stock
Table 70: Sientra Raises USD115 Million in Public Offering of Shares
Table 71: Salter Labs and SunMed Holdings Merge
Table 72: Olympus Enters into Distribution Agreement with Rocamed
Table 73: CorTechs Labs and Imaging Biometrics Enter into Distribution Agreement
Table 74: Osprey Medical to Raise up to USD9.4 Million in Entitlement Offer of CDI
Table 75: Rockwell Medical to Raise USD15 Million in Private Financing
Table 76: Flow Forward Medical to Raise Funds through Venture Financing
Table 77: US Kidney Research Raises USD0.5 Million in Venture Financing
Table 78: Outset Medical Raises USD125 Million in Series E Financing
Table 79: Solace Therapeutics Raises USD4 Million in Venture Financing
Table 80: Kyra Medical Raises USD0.1 Million in Venture Financing
Table 81: Kyra Medical Raises USD0.16 Million in Venture Financing
Table 82: SonoMotion Raises USD10 Million in Series B Financing
Table 83: Pelvital USA Raises USD1 Million in Venture Financing
Table 84: Kalera Medical Raises Funds through Venture Financing
Table 85: Healionics Raises USD4.5 Million in Financing Round
Table 86: MediBeacon Raises USD34.3 Million in Venture Financing
Table 87: Renalert Raises Funds through Venture Financing
Table 88: VenoStent Raises USD0.3 Million in Venture Financing
Table 89: Corinth MedTech Raises USD12 Million in Series D Financing
Table 90: Diality Raises USD10 Million in Series A Financing
Table 91: Kyra Medical Raises USD0.2 Million in Venture Financing
Table 92: Vesiflo Raises USD0.1 Million in Venture Financing
Table 93: ClearFlow Raises USD7.6 Million in Venture Financing
Table 94: Kalera Medical Raises USD0.5 Million in Venture Financing
Table 95: Sonomotion Raises USD3.3 Million in Venture Financing
Table 96: HistoSonics Raises USD54 Million in Series C Financing

LIST OF FIGURES

Figure 1: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025
Figure 4: Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025
Figure 5: Nephrology and Urology Devices Market, United States, Company Share (%) 2019
Figure 6: Renal Dialysis Equipment Market, United States, Revenue Mix ($m), 2019
Figure 7: Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2019
Figure 8: Renal Dialysis Equipment Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 9: Dialysis Accessories Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 10: Dialysis Machines Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 11: Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 12: Renal Dialysis Equipment Market, United States, Volume (Units), 2015-2025
Figure 13: Dialysis Accessories Market, United States, Volume (Units), 2015-2025
Figure 14: Dialysis Machines Market, United States, Volume (Units), 2015-2025
Figure 15: Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), 2015-2025
Figure 16: Renal Dialysis Equipment Market, United States, Company Share (%) 2019

COMPANIES MENTIONED

Fresenius Medical Care AG & Co KGaA
Baxter International Inc
Nipro Corp


More Publications